These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 20402565

  • 1. Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention.
    Nicholl D, Nasrallah H, Nuamah I, Akhras K, Gagnon DD, Gopal S.
    Curr Med Res Opin; 2010 Jun; 26(6):1471-84. PubMed ID: 20402565
    [Abstract] [Full Text] [Related]

  • 2. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL, Burns T, Morosini P, Gagnon DD, Rothman M, Adriaenssen I.
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [Abstract] [Full Text] [Related]

  • 3. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
    Nasrallah H, Morosini P, Gagnon DD.
    Psychiatry Res; 2008 Nov 30; 161(2):213-24. PubMed ID: 18848731
    [Abstract] [Full Text] [Related]

  • 4. Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia.
    Canuso CM, Bossie CA, Amatniek J, Turkoz I, Pandina G, Cornblatt B.
    Early Interv Psychiatry; 2010 Feb 30; 4(1):64-78. PubMed ID: 20199482
    [Abstract] [Full Text] [Related]

  • 5. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kramer M, Simpson G, Maciulis V, Kushner S, Vijapurkar U, Lim P, Eerdekens M.
    J Clin Psychopharmacol; 2007 Feb 30; 27(1):6-14. PubMed ID: 17224706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G, Bossie C, Turkoz I, Kujawa M, Mahmoud R, Simpson G.
    J Nerv Ment Dis; 2007 Dec 30; 195(12):976-82. PubMed ID: 18091190
    [Abstract] [Full Text] [Related]

  • 8. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA, Bettinger TL, Argo TR.
    Clin Ther; 2008 Feb 30; 30(2):231-48. PubMed ID: 18343262
    [Abstract] [Full Text] [Related]

  • 9. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 30; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Chinese version of the Personal and Social Performance Scale (PSP): validity and reliability.
    Tianmei S, Liang S, Yun'ai S, Chenghua T, Jun Y, Jia C, Xueni L, Qi L, Yantao M, Weihua Z, Hongyan Z.
    Psychiatry Res; 2011 Jan 30; 185(1-2):275-9. PubMed ID: 20542575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.